Helena Eriksson

Karolinska University Hospital — Sweden

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index788citations73works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

S100 Proteins and Annexins(37), Immune Response and Inflammation(12), Blood Coagulation and Thrombosis Mechanisms(11), Protease and Inhibitor Mechanisms(8), Immune cells in cancer(6)

Publications73 total

IgG2a-formatted 4-1BB agonism combined with S100A9 inhibition enhances T cell activation and tumor control in a preclinical model of multiple myeloma
Blood·2025Open Access
Investigation regarding the occurrence of fowl adenovirus (FAdV) in dead-in-shell chicks and young broiler breeders in Sweden
Avian Pathology·2025Open Access
1617P Leucine-rich 2 glycoprotein 1 (LRG1) as potential systemic biomarker for response to neoadjuvant immune checkpoint blockade in stage III melanoma
Annals of Oncology·2025
Preclinical Efficacy of Tasquinimod in Myelodysplastic Neoplasms: Restoring Erythropoiesis and Mitigating Bone Loss
2025· 1 citedOpen Access
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia
Blood Cancer Journal·2023· 14 citedOpen Access
Tasquinimod Improves Erythropoiesis and Mitigates Bone Loss in Myelodysplastic Mice
Blood·2023Open Access
Figure S8 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S3 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Supplementary Tables S1 and S2 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Data from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Supplementary Tables S1 and S2 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S3 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S5 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S7 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S7 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S5 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S2 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Data from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S6 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
Figure S4 from S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Marie Törngren(26), Thomas Vogl(15), Dan T. Vogl(15), Yulia Nefedova(15), Cindy Lin(14), Laura Garcia-Gerique(14), Erin E. Bonner(14), Jérôme Mastio(14), Matthew Rosenwasser(14), Zachary Cruz(14), Michael Lawler(14), Luca Bernabei(14), Kar Muthumani(14), Qin Liu(14), Mortimer Poncz(14), Dmitry I. Gabrilovich(14), Tomas Leanderson(10), Kim De Veirman(10), Ken Maes(10), Eline Menu(10)